Pharma & Healthcare
Global Anti-Vimentin Antibody Market Research Report 2026
- May 01, 26
- ID: 749371
- Pages: 122
- Figures: 127
- Views: 11
This report delivers a comprehensive overview of the global Anti-Vimentin Antibody market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Anti-Vimentin Antibody. The Anti-Vimentin Antibody market size, estimates, and forecasts are provided in terms of sales volume (kg) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Anti-Vimentin Antibody market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Anti-Vimentin Antibody manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Thermo Fisher Scientific
Nordic
Abcam
Genetex
PROGEN
Bio-Rad
Boster Bio
Sino Biological
Arigo Biolaboratories
Aves Labs
Raybiotech
Biolegend
Roche Diagnostics
Rockland Immunochemicals
Segment by Type
Monoclonal Anti-Vimentin Antibody
Polyclonal Anti-Vimentin Antibody
by Application
Immunocytochemistry
Flow Cytometry
Immunochemistry
Western Blot
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Anti-Vimentin Antibody manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Anti-Vimentin Antibody sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Anti-Vimentin Antibody market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Anti-Vimentin Antibody manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Thermo Fisher Scientific
Nordic
Abcam
Genetex
PROGEN
Bio-Rad
Boster Bio
Sino Biological
Arigo Biolaboratories
Aves Labs
Raybiotech
Biolegend
Roche Diagnostics
Rockland Immunochemicals
Segment by Type
Monoclonal Anti-Vimentin Antibody
Polyclonal Anti-Vimentin Antibody
by Application
Immunocytochemistry
Flow Cytometry
Immunochemistry
Western Blot
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Anti-Vimentin Antibody manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Anti-Vimentin Antibody sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Anti-Vimentin Antibody Market Overview
1.1 Product Definition
1.2 Anti-Vimentin Antibody by Type
1.2.1 Global Anti-Vimentin Antibody Market Value by Type: 2025 vs 2032
1.2.2 Monoclonal Anti-Vimentin Antibody
1.2.3 Polyclonal Anti-Vimentin Antibody
1.3 Anti-Vimentin Antibody by Application
1.3.1 Global Anti-Vimentin Antibody Market Value by Application: 2025 vs 2032
1.3.2 Immunocytochemistry
1.3.3 Flow Cytometry
1.3.4 Immunochemistry
1.3.5 Western Blot
1.3.6 Others
1.4 Global Anti-Vimentin Antibody Market Size Estimates and Forecasts
1.4.1 Global Anti-Vimentin Antibody Revenue 2021–2032
1.4.2 Global Anti-Vimentin Antibody Sales 2021–2032
1.4.3 Global Anti-Vimentin Antibody Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Anti-Vimentin Antibody Market Competition by Manufacturers
2.1 Global Anti-Vimentin Antibody Sales Market Share by Manufacturers (2021–2026)
2.2 Global Anti-Vimentin Antibody Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Anti-Vimentin Antibody Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Anti-Vimentin Antibody, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Anti-Vimentin Antibody, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Anti-Vimentin Antibody, Product Types and Applications
2.7 Global Key Manufacturers of Anti-Vimentin Antibody, Date of Entry into the Industry
2.8 Global Anti-Vimentin Antibody Market Competitive Situation and Trends
2.8.1 Global Anti-Vimentin Antibody Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Anti-Vimentin Antibody Players Market Share by Revenue
2.8.3 Global Anti-Vimentin Antibody Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Anti-Vimentin Antibody Market Scenario by Region
3.1 Global Anti-Vimentin Antibody Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Anti-Vimentin Antibody Sales by Region: 2021–2032
3.2.1 Global Anti-Vimentin Antibody Sales by Region: 2021–2026
3.2.2 Global Anti-Vimentin Antibody Sales by Region: 2027–2032
3.3 Global Anti-Vimentin Antibody Revenue by Region: 2021–2032
3.3.1 Global Anti-Vimentin Antibody Revenue by Region: 2021–2026
3.3.2 Global Anti-Vimentin Antibody Revenue by Region: 2027–2032
3.4 North America Anti-Vimentin Antibody Market Facts & Figures by Country
3.4.1 North America Anti-Vimentin Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Anti-Vimentin Antibody Sales by Country (2021–2032)
3.4.3 North America Anti-Vimentin Antibody Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Anti-Vimentin Antibody Market Facts & Figures by Country
3.5.1 Europe Anti-Vimentin Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Anti-Vimentin Antibody Sales by Country (2021–2032)
3.5.3 Europe Anti-Vimentin Antibody Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-Vimentin Antibody Market Facts & Figures by Region
3.6.1 Asia Pacific Anti-Vimentin Antibody Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Anti-Vimentin Antibody Sales by Region (2021–2032)
3.6.3 Asia Pacific Anti-Vimentin Antibody Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Anti-Vimentin Antibody Market Facts & Figures by Country
3.7.1 Latin America Anti-Vimentin Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Anti-Vimentin Antibody Sales by Country (2021–2032)
3.7.3 Latin America Anti-Vimentin Antibody Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Anti-Vimentin Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-Vimentin Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Anti-Vimentin Antibody Sales by Country (2021–2032)
3.8.3 Middle East and Africa Anti-Vimentin Antibody Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anti-Vimentin Antibody Sales by Type (2021–2032)
4.1.1 Global Anti-Vimentin Antibody Sales by Type (2021–2026)
4.1.2 Global Anti-Vimentin Antibody Sales by Type (2027–2032)
4.1.3 Global Anti-Vimentin Antibody Sales Market Share by Type (2021–2032)
4.2 Global Anti-Vimentin Antibody Revenue by Type (2021–2032)
4.2.1 Global Anti-Vimentin Antibody Revenue by Type (2021–2026)
4.2.2 Global Anti-Vimentin Antibody Revenue by Type (2027–2032)
4.2.3 Global Anti-Vimentin Antibody Revenue Market Share by Type (2021–2032)
4.3 Global Anti-Vimentin Antibody Price by Type (2021–2032)
5 Segment by Application
5.1 Global Anti-Vimentin Antibody Sales by Application (2021–2032)
5.1.1 Global Anti-Vimentin Antibody Sales by Application (2021–2026)
5.1.2 Global Anti-Vimentin Antibody Sales by Application (2027–2032)
5.1.3 Global Anti-Vimentin Antibody Sales Market Share by Application (2021–2032)
5.2 Global Anti-Vimentin Antibody Revenue by Application (2021–2032)
5.2.1 Global Anti-Vimentin Antibody Revenue by Application (2021–2026)
5.2.2 Global Anti-Vimentin Antibody Revenue by Application (2027–2032)
5.2.3 Global Anti-Vimentin Antibody Revenue Market Share by Application (2021–2032)
5.3 Global Anti-Vimentin Antibody Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Thermo Fisher Scientific
6.1.1 Thermo Fisher Scientific Company Information
6.1.2 Thermo Fisher Scientific Description and Business Overview
6.1.3 Thermo Fisher Scientific Anti-Vimentin Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Thermo Fisher Scientific Anti-Vimentin Antibody Product Portfolio
6.1.5 Thermo Fisher Scientific Recent Developments/Updates
6.2 Nordic
6.2.1 Nordic Company Information
6.2.2 Nordic Description and Business Overview
6.2.3 Nordic Anti-Vimentin Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Nordic Anti-Vimentin Antibody Product Portfolio
6.2.5 Nordic Recent Developments/Updates
6.3 Abcam
6.3.1 Abcam Company Information
6.3.2 Abcam Description and Business Overview
6.3.3 Abcam Anti-Vimentin Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Abcam Anti-Vimentin Antibody Product Portfolio
6.3.5 Abcam Recent Developments/Updates
6.4 Genetex
6.4.1 Genetex Company Information
6.4.2 Genetex Description and Business Overview
6.4.3 Genetex Anti-Vimentin Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Genetex Anti-Vimentin Antibody Product Portfolio
6.4.5 Genetex Recent Developments/Updates
6.5 PROGEN
6.5.1 PROGEN Company Information
6.5.2 PROGEN Description and Business Overview
6.5.3 PROGEN Anti-Vimentin Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 PROGEN Anti-Vimentin Antibody Product Portfolio
6.5.5 PROGEN Recent Developments/Updates
6.6 Bio-Rad
6.6.1 Bio-Rad Company Information
6.6.2 Bio-Rad Description and Business Overview
6.6.3 Bio-Rad Anti-Vimentin Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Bio-Rad Anti-Vimentin Antibody Product Portfolio
6.6.5 Bio-Rad Recent Developments/Updates
6.7 Boster Bio
6.7.1 Boster Bio Company Information
6.7.2 Boster Bio Description and Business Overview
6.7.3 Boster Bio Anti-Vimentin Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Boster Bio Anti-Vimentin Antibody Product Portfolio
6.7.5 Boster Bio Recent Developments/Updates
6.8 Sino Biological
6.8.1 Sino Biological Company Information
6.8.2 Sino Biological Description and Business Overview
6.8.3 Sino Biological Anti-Vimentin Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Sino Biological Anti-Vimentin Antibody Product Portfolio
6.8.5 Sino Biological Recent Developments/Updates
6.9 Arigo Biolaboratories
6.9.1 Arigo Biolaboratories Company Information
6.9.2 Arigo Biolaboratories Description and Business Overview
6.9.3 Arigo Biolaboratories Anti-Vimentin Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Arigo Biolaboratories Anti-Vimentin Antibody Product Portfolio
6.9.5 Arigo Biolaboratories Recent Developments/Updates
6.10 Aves Labs
6.10.1 Aves Labs Company Information
6.10.2 Aves Labs Description and Business Overview
6.10.3 Aves Labs Anti-Vimentin Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Aves Labs Anti-Vimentin Antibody Product Portfolio
6.10.5 Aves Labs Recent Developments/Updates
6.11 Raybiotech
6.11.1 Raybiotech Company Information
6.11.2 Raybiotech Description and Business Overview
6.11.3 Raybiotech Anti-Vimentin Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Raybiotech Anti-Vimentin Antibody Product Portfolio
6.11.5 Raybiotech Recent Developments/Updates
6.12 Biolegend
6.12.1 Biolegend Company Information
6.12.2 Biolegend Description and Business Overview
6.12.3 Biolegend Anti-Vimentin Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Biolegend Anti-Vimentin Antibody Product Portfolio
6.12.5 Biolegend Recent Developments/Updates
6.13 Roche Diagnostics
6.13.1 Roche Diagnostics Company Information
6.13.2 Roche Diagnostics Description and Business Overview
6.13.3 Roche Diagnostics Anti-Vimentin Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Roche Diagnostics Anti-Vimentin Antibody Product Portfolio
6.13.5 Roche Diagnostics Recent Developments/Updates
6.14 Rockland Immunochemicals
6.14.1 Rockland Immunochemicals Company Information
6.14.2 Rockland Immunochemicals Description and Business Overview
6.14.3 Rockland Immunochemicals Anti-Vimentin Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Rockland Immunochemicals Anti-Vimentin Antibody Product Portfolio
6.14.5 Rockland Immunochemicals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-Vimentin Antibody Industry Chain Analysis
7.2 Anti-Vimentin Antibody Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-Vimentin Antibody Production Mode & Process Analysis
7.4 Anti-Vimentin Antibody Sales and Marketing
7.4.1 Anti-Vimentin Antibody Sales Channels
7.4.2 Anti-Vimentin Antibody Distributors
7.5 Anti-Vimentin Antibody Customer Analysis
8 Anti-Vimentin Antibody Market Dynamics
8.1 Anti-Vimentin Antibody Industry Trends
8.2 Anti-Vimentin Antibody Market Drivers
8.3 Anti-Vimentin Antibody Market Challenges
8.4 Anti-Vimentin Antibody Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Anti-Vimentin Antibody by Type
1.2.1 Global Anti-Vimentin Antibody Market Value by Type: 2025 vs 2032
1.2.2 Monoclonal Anti-Vimentin Antibody
1.2.3 Polyclonal Anti-Vimentin Antibody
1.3 Anti-Vimentin Antibody by Application
1.3.1 Global Anti-Vimentin Antibody Market Value by Application: 2025 vs 2032
1.3.2 Immunocytochemistry
1.3.3 Flow Cytometry
1.3.4 Immunochemistry
1.3.5 Western Blot
1.3.6 Others
1.4 Global Anti-Vimentin Antibody Market Size Estimates and Forecasts
1.4.1 Global Anti-Vimentin Antibody Revenue 2021–2032
1.4.2 Global Anti-Vimentin Antibody Sales 2021–2032
1.4.3 Global Anti-Vimentin Antibody Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Anti-Vimentin Antibody Market Competition by Manufacturers
2.1 Global Anti-Vimentin Antibody Sales Market Share by Manufacturers (2021–2026)
2.2 Global Anti-Vimentin Antibody Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Anti-Vimentin Antibody Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Anti-Vimentin Antibody, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Anti-Vimentin Antibody, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Anti-Vimentin Antibody, Product Types and Applications
2.7 Global Key Manufacturers of Anti-Vimentin Antibody, Date of Entry into the Industry
2.8 Global Anti-Vimentin Antibody Market Competitive Situation and Trends
2.8.1 Global Anti-Vimentin Antibody Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Anti-Vimentin Antibody Players Market Share by Revenue
2.8.3 Global Anti-Vimentin Antibody Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Anti-Vimentin Antibody Market Scenario by Region
3.1 Global Anti-Vimentin Antibody Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Anti-Vimentin Antibody Sales by Region: 2021–2032
3.2.1 Global Anti-Vimentin Antibody Sales by Region: 2021–2026
3.2.2 Global Anti-Vimentin Antibody Sales by Region: 2027–2032
3.3 Global Anti-Vimentin Antibody Revenue by Region: 2021–2032
3.3.1 Global Anti-Vimentin Antibody Revenue by Region: 2021–2026
3.3.2 Global Anti-Vimentin Antibody Revenue by Region: 2027–2032
3.4 North America Anti-Vimentin Antibody Market Facts & Figures by Country
3.4.1 North America Anti-Vimentin Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Anti-Vimentin Antibody Sales by Country (2021–2032)
3.4.3 North America Anti-Vimentin Antibody Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Anti-Vimentin Antibody Market Facts & Figures by Country
3.5.1 Europe Anti-Vimentin Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Anti-Vimentin Antibody Sales by Country (2021–2032)
3.5.3 Europe Anti-Vimentin Antibody Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-Vimentin Antibody Market Facts & Figures by Region
3.6.1 Asia Pacific Anti-Vimentin Antibody Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Anti-Vimentin Antibody Sales by Region (2021–2032)
3.6.3 Asia Pacific Anti-Vimentin Antibody Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Anti-Vimentin Antibody Market Facts & Figures by Country
3.7.1 Latin America Anti-Vimentin Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Anti-Vimentin Antibody Sales by Country (2021–2032)
3.7.3 Latin America Anti-Vimentin Antibody Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Anti-Vimentin Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-Vimentin Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Anti-Vimentin Antibody Sales by Country (2021–2032)
3.8.3 Middle East and Africa Anti-Vimentin Antibody Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anti-Vimentin Antibody Sales by Type (2021–2032)
4.1.1 Global Anti-Vimentin Antibody Sales by Type (2021–2026)
4.1.2 Global Anti-Vimentin Antibody Sales by Type (2027–2032)
4.1.3 Global Anti-Vimentin Antibody Sales Market Share by Type (2021–2032)
4.2 Global Anti-Vimentin Antibody Revenue by Type (2021–2032)
4.2.1 Global Anti-Vimentin Antibody Revenue by Type (2021–2026)
4.2.2 Global Anti-Vimentin Antibody Revenue by Type (2027–2032)
4.2.3 Global Anti-Vimentin Antibody Revenue Market Share by Type (2021–2032)
4.3 Global Anti-Vimentin Antibody Price by Type (2021–2032)
5 Segment by Application
5.1 Global Anti-Vimentin Antibody Sales by Application (2021–2032)
5.1.1 Global Anti-Vimentin Antibody Sales by Application (2021–2026)
5.1.2 Global Anti-Vimentin Antibody Sales by Application (2027–2032)
5.1.3 Global Anti-Vimentin Antibody Sales Market Share by Application (2021–2032)
5.2 Global Anti-Vimentin Antibody Revenue by Application (2021–2032)
5.2.1 Global Anti-Vimentin Antibody Revenue by Application (2021–2026)
5.2.2 Global Anti-Vimentin Antibody Revenue by Application (2027–2032)
5.2.3 Global Anti-Vimentin Antibody Revenue Market Share by Application (2021–2032)
5.3 Global Anti-Vimentin Antibody Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Thermo Fisher Scientific
6.1.1 Thermo Fisher Scientific Company Information
6.1.2 Thermo Fisher Scientific Description and Business Overview
6.1.3 Thermo Fisher Scientific Anti-Vimentin Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Thermo Fisher Scientific Anti-Vimentin Antibody Product Portfolio
6.1.5 Thermo Fisher Scientific Recent Developments/Updates
6.2 Nordic
6.2.1 Nordic Company Information
6.2.2 Nordic Description and Business Overview
6.2.3 Nordic Anti-Vimentin Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Nordic Anti-Vimentin Antibody Product Portfolio
6.2.5 Nordic Recent Developments/Updates
6.3 Abcam
6.3.1 Abcam Company Information
6.3.2 Abcam Description and Business Overview
6.3.3 Abcam Anti-Vimentin Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Abcam Anti-Vimentin Antibody Product Portfolio
6.3.5 Abcam Recent Developments/Updates
6.4 Genetex
6.4.1 Genetex Company Information
6.4.2 Genetex Description and Business Overview
6.4.3 Genetex Anti-Vimentin Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Genetex Anti-Vimentin Antibody Product Portfolio
6.4.5 Genetex Recent Developments/Updates
6.5 PROGEN
6.5.1 PROGEN Company Information
6.5.2 PROGEN Description and Business Overview
6.5.3 PROGEN Anti-Vimentin Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 PROGEN Anti-Vimentin Antibody Product Portfolio
6.5.5 PROGEN Recent Developments/Updates
6.6 Bio-Rad
6.6.1 Bio-Rad Company Information
6.6.2 Bio-Rad Description and Business Overview
6.6.3 Bio-Rad Anti-Vimentin Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Bio-Rad Anti-Vimentin Antibody Product Portfolio
6.6.5 Bio-Rad Recent Developments/Updates
6.7 Boster Bio
6.7.1 Boster Bio Company Information
6.7.2 Boster Bio Description and Business Overview
6.7.3 Boster Bio Anti-Vimentin Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Boster Bio Anti-Vimentin Antibody Product Portfolio
6.7.5 Boster Bio Recent Developments/Updates
6.8 Sino Biological
6.8.1 Sino Biological Company Information
6.8.2 Sino Biological Description and Business Overview
6.8.3 Sino Biological Anti-Vimentin Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Sino Biological Anti-Vimentin Antibody Product Portfolio
6.8.5 Sino Biological Recent Developments/Updates
6.9 Arigo Biolaboratories
6.9.1 Arigo Biolaboratories Company Information
6.9.2 Arigo Biolaboratories Description and Business Overview
6.9.3 Arigo Biolaboratories Anti-Vimentin Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Arigo Biolaboratories Anti-Vimentin Antibody Product Portfolio
6.9.5 Arigo Biolaboratories Recent Developments/Updates
6.10 Aves Labs
6.10.1 Aves Labs Company Information
6.10.2 Aves Labs Description and Business Overview
6.10.3 Aves Labs Anti-Vimentin Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Aves Labs Anti-Vimentin Antibody Product Portfolio
6.10.5 Aves Labs Recent Developments/Updates
6.11 Raybiotech
6.11.1 Raybiotech Company Information
6.11.2 Raybiotech Description and Business Overview
6.11.3 Raybiotech Anti-Vimentin Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Raybiotech Anti-Vimentin Antibody Product Portfolio
6.11.5 Raybiotech Recent Developments/Updates
6.12 Biolegend
6.12.1 Biolegend Company Information
6.12.2 Biolegend Description and Business Overview
6.12.3 Biolegend Anti-Vimentin Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Biolegend Anti-Vimentin Antibody Product Portfolio
6.12.5 Biolegend Recent Developments/Updates
6.13 Roche Diagnostics
6.13.1 Roche Diagnostics Company Information
6.13.2 Roche Diagnostics Description and Business Overview
6.13.3 Roche Diagnostics Anti-Vimentin Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Roche Diagnostics Anti-Vimentin Antibody Product Portfolio
6.13.5 Roche Diagnostics Recent Developments/Updates
6.14 Rockland Immunochemicals
6.14.1 Rockland Immunochemicals Company Information
6.14.2 Rockland Immunochemicals Description and Business Overview
6.14.3 Rockland Immunochemicals Anti-Vimentin Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Rockland Immunochemicals Anti-Vimentin Antibody Product Portfolio
6.14.5 Rockland Immunochemicals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-Vimentin Antibody Industry Chain Analysis
7.2 Anti-Vimentin Antibody Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-Vimentin Antibody Production Mode & Process Analysis
7.4 Anti-Vimentin Antibody Sales and Marketing
7.4.1 Anti-Vimentin Antibody Sales Channels
7.4.2 Anti-Vimentin Antibody Distributors
7.5 Anti-Vimentin Antibody Customer Analysis
8 Anti-Vimentin Antibody Market Dynamics
8.1 Anti-Vimentin Antibody Industry Trends
8.2 Anti-Vimentin Antibody Market Drivers
8.3 Anti-Vimentin Antibody Market Challenges
8.4 Anti-Vimentin Antibody Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Anti-Vimentin Antibody Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Anti-Vimentin Antibody Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Anti-Vimentin Antibody Market Competitive Situation by Manufacturers in 2025
Table 4. Global Anti-Vimentin Antibody Sales (kg) of Key Manufacturers (2021–2026)
Table 5. Global Anti-Vimentin Antibody Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Anti-Vimentin Antibody Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Anti-Vimentin Antibody Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Anti-Vimentin Antibody Average Price (US$/kg) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Anti-Vimentin Antibody, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Anti-Vimentin Antibody, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Anti-Vimentin Antibody, Product Types and Applications
Table 12. Global Key Manufacturers of Anti-Vimentin Antibody, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti-Vimentin Antibody Companies by Tier (Tier 1, Tier 2, Tier 3), based on Anti-Vimentin Antibody Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-Vimentin Antibody Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Anti-Vimentin Antibody Sales by Region (kg), 2021–2026
Table 18. Global Anti-Vimentin Antibody Sales Market Share by Region (2021–2026)
Table 19. Global Anti-Vimentin Antibody Sales by Region (kg), 2027–2032
Table 20. Global Anti-Vimentin Antibody Sales Market Share by Region (2027–2032)
Table 21. Global Anti-Vimentin Antibody Revenue by Region (US$ Million), 2021–2026
Table 22. Global Anti-Vimentin Antibody Revenue Market Share by Region (2021–2026)
Table 23. Global Anti-Vimentin Antibody Revenue by Region (US$ Million), 2027–2032
Table 24. Global Anti-Vimentin Antibody Revenue Market Share by Region (2027–2032)
Table 25. North America Anti-Vimentin Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Anti-Vimentin Antibody Sales by Country (kg), 2021–2026
Table 27. North America Anti-Vimentin Antibody Sales by Country (kg), 2027–2032
Table 28. North America Anti-Vimentin Antibody Revenue by Country (US$ Million), 2021–2026
Table 29. North America Anti-Vimentin Antibody Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Anti-Vimentin Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Anti-Vimentin Antibody Sales by Country (kg), 2021–2026
Table 32. Europe Anti-Vimentin Antibody Sales by Country (kg), 2027–2032
Table 33. Europe Anti-Vimentin Antibody Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Anti-Vimentin Antibody Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Anti-Vimentin Antibody Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Anti-Vimentin Antibody Sales by Region (kg), 2021–2026
Table 37. Asia Pacific Anti-Vimentin Antibody Sales by Region (kg), 2027–2032
Table 38. Asia Pacific Anti-Vimentin Antibody Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Anti-Vimentin Antibody Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Anti-Vimentin Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Anti-Vimentin Antibody Sales by Country (kg), 2021–2026
Table 42. Latin America Anti-Vimentin Antibody Sales by Country (kg), 2027–2032
Table 43. Latin America Anti-Vimentin Antibody Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Anti-Vimentin Antibody Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Anti-Vimentin Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Anti-Vimentin Antibody Sales by Country (kg), 2021–2026
Table 47. Middle East and Africa Anti-Vimentin Antibody Sales by Country (kg), 2027–2032
Table 48. Middle East and Africa Anti-Vimentin Antibody Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Anti-Vimentin Antibody Revenue by Country (US$ Million), 2027–2032
Table 50. Global Anti-Vimentin Antibody Sales (kg) by Type (2021–2026)
Table 51. Global Anti-Vimentin Antibody Sales (kg) by Type (2027–2032)
Table 52. Global Anti-Vimentin Antibody Sales Market Share by Type (2021–2026)
Table 53. Global Anti-Vimentin Antibody Sales Market Share by Type (2027–2032)
Table 54. Global Anti-Vimentin Antibody Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Anti-Vimentin Antibody Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Anti-Vimentin Antibody Revenue Market Share by Type (2021–2026)
Table 57. Global Anti-Vimentin Antibody Revenue Market Share by Type (2027–2032)
Table 58. Global Anti-Vimentin Antibody Price (US$/kg) by Type (2021–2026)
Table 59. Global Anti-Vimentin Antibody Price (US$/kg) by Type (2027–2032)
Table 60. Global Anti-Vimentin Antibody Sales (kg) by Application (2021–2026)
Table 61. Global Anti-Vimentin Antibody Sales (kg) by Application (2027–2032)
Table 62. Global Anti-Vimentin Antibody Sales Market Share by Application (2021–2026)
Table 63. Global Anti-Vimentin Antibody Sales Market Share by Application (2027–2032)
Table 64. Global Anti-Vimentin Antibody Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Anti-Vimentin Antibody Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Anti-Vimentin Antibody Revenue Market Share by Application (2021–2026)
Table 67. Global Anti-Vimentin Antibody Revenue Market Share by Application (2027–2032)
Table 68. Global Anti-Vimentin Antibody Price (US$/kg) by Application (2021–2026)
Table 69. Global Anti-Vimentin Antibody Price (US$/kg) by Application (2027–2032)
Table 70. Thermo Fisher Scientific Company Information
Table 71. Thermo Fisher Scientific Description and Business Overview
Table 72. Thermo Fisher Scientific Anti-Vimentin Antibody Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 73. Thermo Fisher Scientific Anti-Vimentin Antibody Product
Table 74. Thermo Fisher Scientific Recent Developments/Updates
Table 75. Nordic Company Information
Table 76. Nordic Description and Business Overview
Table 77. Nordic Anti-Vimentin Antibody Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 78. Nordic Anti-Vimentin Antibody Product
Table 79. Nordic Recent Developments/Updates
Table 80. Abcam Company Information
Table 81. Abcam Description and Business Overview
Table 82. Abcam Anti-Vimentin Antibody Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 83. Abcam Anti-Vimentin Antibody Product
Table 84. Abcam Recent Developments/Updates
Table 85. Genetex Company Information
Table 86. Genetex Description and Business Overview
Table 87. Genetex Anti-Vimentin Antibody Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 88. Genetex Anti-Vimentin Antibody Product
Table 89. Genetex Recent Developments/Updates
Table 90. PROGEN Company Information
Table 91. PROGEN Description and Business Overview
Table 92. PROGEN Anti-Vimentin Antibody Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 93. PROGEN Anti-Vimentin Antibody Product
Table 94. PROGEN Recent Developments/Updates
Table 95. Bio-Rad Company Information
Table 96. Bio-Rad Description and Business Overview
Table 97. Bio-Rad Anti-Vimentin Antibody Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 98. Bio-Rad Anti-Vimentin Antibody Product
Table 99. Bio-Rad Recent Developments/Updates
Table 100. Boster Bio Company Information
Table 101. Boster Bio Description and Business Overview
Table 102. Boster Bio Anti-Vimentin Antibody Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 103. Boster Bio Anti-Vimentin Antibody Product
Table 104. Boster Bio Recent Developments/Updates
Table 105. Sino Biological Company Information
Table 106. Sino Biological Description and Business Overview
Table 107. Sino Biological Anti-Vimentin Antibody Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 108. Sino Biological Anti-Vimentin Antibody Product
Table 109. Sino Biological Recent Developments/Updates
Table 110. Arigo Biolaboratories Company Information
Table 111. Arigo Biolaboratories Description and Business Overview
Table 112. Arigo Biolaboratories Anti-Vimentin Antibody Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 113. Arigo Biolaboratories Anti-Vimentin Antibody Product
Table 114. Arigo Biolaboratories Recent Developments/Updates
Table 115. Aves Labs Company Information
Table 116. Aves Labs Description and Business Overview
Table 117. Aves Labs Anti-Vimentin Antibody Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 118. Aves Labs Anti-Vimentin Antibody Product
Table 119. Aves Labs Recent Developments/Updates
Table 120. Raybiotech Company Information
Table 121. Raybiotech Description and Business Overview
Table 122. Raybiotech Anti-Vimentin Antibody Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 123. Raybiotech Anti-Vimentin Antibody Product
Table 124. Raybiotech Recent Developments/Updates
Table 125. Biolegend Company Information
Table 126. Biolegend Description and Business Overview
Table 127. Biolegend Anti-Vimentin Antibody Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 128. Biolegend Anti-Vimentin Antibody Product
Table 129. Biolegend Recent Developments/Updates
Table 130. Roche Diagnostics Company Information
Table 131. Roche Diagnostics Description and Business Overview
Table 132. Roche Diagnostics Anti-Vimentin Antibody Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 133. Roche Diagnostics Anti-Vimentin Antibody Product
Table 134. Roche Diagnostics Recent Developments/Updates
Table 135. Rockland Immunochemicals Company Information
Table 136. Rockland Immunochemicals Description and Business Overview
Table 137. Rockland Immunochemicals Anti-Vimentin Antibody Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 138. Rockland Immunochemicals Anti-Vimentin Antibody Product
Table 139. Rockland Immunochemicals Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Anti-Vimentin Antibody Distributors List
Table 143. Anti-Vimentin Antibody Customers List
Table 144. Anti-Vimentin Antibody Market Trends
Table 145. Anti-Vimentin Antibody Market Drivers
Table 146. Anti-Vimentin Antibody Market Challenges
Table 147. Anti-Vimentin Antibody Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Anti-Vimentin Antibody
Figure 2. Global Anti-Vimentin Antibody Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Anti-Vimentin Antibody Market Share by Type: 2025 & 2032
Figure 4. Monoclonal Anti-Vimentin Antibody Product Picture
Figure 5. Polyclonal Anti-Vimentin Antibody Product Picture
Figure 6. Global Anti-Vimentin Antibody Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Anti-Vimentin Antibody Market Share by Application: 2025 & 2032
Figure 8. Immunocytochemistry
Figure 9. Flow Cytometry
Figure 10. Immunochemistry
Figure 11. Western Blot
Figure 12. Others
Figure 13. Global Anti-Vimentin Antibody Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Anti-Vimentin Antibody Market Size (US$ Million), 2021–2032
Figure 15. Global Anti-Vimentin Antibody Sales (kg), 2021–2032
Figure 16. Global Anti-Vimentin Antibody Average Price (US$/kg), 2021–2032
Figure 17. Anti-Vimentin Antibody Report Years Considered
Figure 18. Anti-Vimentin Antibody Sales Share by Manufacturers in 2025
Figure 19. Global Anti-Vimentin Antibody Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Anti-Vimentin Antibody Players: Market Share by Revenue in Anti-Vimentin Antibody in 2025
Figure 21. Anti-Vimentin Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Anti-Vimentin Antibody Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Anti-Vimentin Antibody Sales Market Share by Country (2021–2032)
Figure 24. North America Anti-Vimentin Antibody Revenue Market Share by Country (2021–2032)
Figure 25. United States Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Anti-Vimentin Antibody Sales Market Share by Country (2021–2032)
Figure 28. Europe Anti-Vimentin Antibody Revenue Market Share by Country (2021–2032)
Figure 29. Germany Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Anti-Vimentin Antibody Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Anti-Vimentin Antibody Revenue Market Share by Region (2021–2032)
Figure 36. China Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Anti-Vimentin Antibody Sales Market Share by Country (2021–2032)
Figure 44. Latin America Anti-Vimentin Antibody Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Anti-Vimentin Antibody Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Anti-Vimentin Antibody Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Anti-Vimentin Antibody by Type (2021–2032)
Figure 55. Global Revenue Market Share of Anti-Vimentin Antibody by Type (2021–2032)
Figure 56. Global Anti-Vimentin Antibody Price (US$/kg) by Type (2021–2032)
Figure 57. Global Sales Market Share of Anti-Vimentin Antibody by Application (2021–2032)
Figure 58. Global Revenue Market Share of Anti-Vimentin Antibody by Application (2021–2032)
Figure 59. Global Anti-Vimentin Antibody Price (US$/kg) by Application (2021–2032)
Figure 60. Anti-Vimentin Antibody Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Anti-Vimentin Antibody Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Anti-Vimentin Antibody Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Anti-Vimentin Antibody Market Competitive Situation by Manufacturers in 2025
Table 4. Global Anti-Vimentin Antibody Sales (kg) of Key Manufacturers (2021–2026)
Table 5. Global Anti-Vimentin Antibody Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Anti-Vimentin Antibody Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Anti-Vimentin Antibody Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Anti-Vimentin Antibody Average Price (US$/kg) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Anti-Vimentin Antibody, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Anti-Vimentin Antibody, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Anti-Vimentin Antibody, Product Types and Applications
Table 12. Global Key Manufacturers of Anti-Vimentin Antibody, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti-Vimentin Antibody Companies by Tier (Tier 1, Tier 2, Tier 3), based on Anti-Vimentin Antibody Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-Vimentin Antibody Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Anti-Vimentin Antibody Sales by Region (kg), 2021–2026
Table 18. Global Anti-Vimentin Antibody Sales Market Share by Region (2021–2026)
Table 19. Global Anti-Vimentin Antibody Sales by Region (kg), 2027–2032
Table 20. Global Anti-Vimentin Antibody Sales Market Share by Region (2027–2032)
Table 21. Global Anti-Vimentin Antibody Revenue by Region (US$ Million), 2021–2026
Table 22. Global Anti-Vimentin Antibody Revenue Market Share by Region (2021–2026)
Table 23. Global Anti-Vimentin Antibody Revenue by Region (US$ Million), 2027–2032
Table 24. Global Anti-Vimentin Antibody Revenue Market Share by Region (2027–2032)
Table 25. North America Anti-Vimentin Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Anti-Vimentin Antibody Sales by Country (kg), 2021–2026
Table 27. North America Anti-Vimentin Antibody Sales by Country (kg), 2027–2032
Table 28. North America Anti-Vimentin Antibody Revenue by Country (US$ Million), 2021–2026
Table 29. North America Anti-Vimentin Antibody Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Anti-Vimentin Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Anti-Vimentin Antibody Sales by Country (kg), 2021–2026
Table 32. Europe Anti-Vimentin Antibody Sales by Country (kg), 2027–2032
Table 33. Europe Anti-Vimentin Antibody Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Anti-Vimentin Antibody Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Anti-Vimentin Antibody Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Anti-Vimentin Antibody Sales by Region (kg), 2021–2026
Table 37. Asia Pacific Anti-Vimentin Antibody Sales by Region (kg), 2027–2032
Table 38. Asia Pacific Anti-Vimentin Antibody Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Anti-Vimentin Antibody Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Anti-Vimentin Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Anti-Vimentin Antibody Sales by Country (kg), 2021–2026
Table 42. Latin America Anti-Vimentin Antibody Sales by Country (kg), 2027–2032
Table 43. Latin America Anti-Vimentin Antibody Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Anti-Vimentin Antibody Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Anti-Vimentin Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Anti-Vimentin Antibody Sales by Country (kg), 2021–2026
Table 47. Middle East and Africa Anti-Vimentin Antibody Sales by Country (kg), 2027–2032
Table 48. Middle East and Africa Anti-Vimentin Antibody Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Anti-Vimentin Antibody Revenue by Country (US$ Million), 2027–2032
Table 50. Global Anti-Vimentin Antibody Sales (kg) by Type (2021–2026)
Table 51. Global Anti-Vimentin Antibody Sales (kg) by Type (2027–2032)
Table 52. Global Anti-Vimentin Antibody Sales Market Share by Type (2021–2026)
Table 53. Global Anti-Vimentin Antibody Sales Market Share by Type (2027–2032)
Table 54. Global Anti-Vimentin Antibody Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Anti-Vimentin Antibody Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Anti-Vimentin Antibody Revenue Market Share by Type (2021–2026)
Table 57. Global Anti-Vimentin Antibody Revenue Market Share by Type (2027–2032)
Table 58. Global Anti-Vimentin Antibody Price (US$/kg) by Type (2021–2026)
Table 59. Global Anti-Vimentin Antibody Price (US$/kg) by Type (2027–2032)
Table 60. Global Anti-Vimentin Antibody Sales (kg) by Application (2021–2026)
Table 61. Global Anti-Vimentin Antibody Sales (kg) by Application (2027–2032)
Table 62. Global Anti-Vimentin Antibody Sales Market Share by Application (2021–2026)
Table 63. Global Anti-Vimentin Antibody Sales Market Share by Application (2027–2032)
Table 64. Global Anti-Vimentin Antibody Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Anti-Vimentin Antibody Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Anti-Vimentin Antibody Revenue Market Share by Application (2021–2026)
Table 67. Global Anti-Vimentin Antibody Revenue Market Share by Application (2027–2032)
Table 68. Global Anti-Vimentin Antibody Price (US$/kg) by Application (2021–2026)
Table 69. Global Anti-Vimentin Antibody Price (US$/kg) by Application (2027–2032)
Table 70. Thermo Fisher Scientific Company Information
Table 71. Thermo Fisher Scientific Description and Business Overview
Table 72. Thermo Fisher Scientific Anti-Vimentin Antibody Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 73. Thermo Fisher Scientific Anti-Vimentin Antibody Product
Table 74. Thermo Fisher Scientific Recent Developments/Updates
Table 75. Nordic Company Information
Table 76. Nordic Description and Business Overview
Table 77. Nordic Anti-Vimentin Antibody Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 78. Nordic Anti-Vimentin Antibody Product
Table 79. Nordic Recent Developments/Updates
Table 80. Abcam Company Information
Table 81. Abcam Description and Business Overview
Table 82. Abcam Anti-Vimentin Antibody Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 83. Abcam Anti-Vimentin Antibody Product
Table 84. Abcam Recent Developments/Updates
Table 85. Genetex Company Information
Table 86. Genetex Description and Business Overview
Table 87. Genetex Anti-Vimentin Antibody Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 88. Genetex Anti-Vimentin Antibody Product
Table 89. Genetex Recent Developments/Updates
Table 90. PROGEN Company Information
Table 91. PROGEN Description and Business Overview
Table 92. PROGEN Anti-Vimentin Antibody Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 93. PROGEN Anti-Vimentin Antibody Product
Table 94. PROGEN Recent Developments/Updates
Table 95. Bio-Rad Company Information
Table 96. Bio-Rad Description and Business Overview
Table 97. Bio-Rad Anti-Vimentin Antibody Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 98. Bio-Rad Anti-Vimentin Antibody Product
Table 99. Bio-Rad Recent Developments/Updates
Table 100. Boster Bio Company Information
Table 101. Boster Bio Description and Business Overview
Table 102. Boster Bio Anti-Vimentin Antibody Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 103. Boster Bio Anti-Vimentin Antibody Product
Table 104. Boster Bio Recent Developments/Updates
Table 105. Sino Biological Company Information
Table 106. Sino Biological Description and Business Overview
Table 107. Sino Biological Anti-Vimentin Antibody Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 108. Sino Biological Anti-Vimentin Antibody Product
Table 109. Sino Biological Recent Developments/Updates
Table 110. Arigo Biolaboratories Company Information
Table 111. Arigo Biolaboratories Description and Business Overview
Table 112. Arigo Biolaboratories Anti-Vimentin Antibody Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 113. Arigo Biolaboratories Anti-Vimentin Antibody Product
Table 114. Arigo Biolaboratories Recent Developments/Updates
Table 115. Aves Labs Company Information
Table 116. Aves Labs Description and Business Overview
Table 117. Aves Labs Anti-Vimentin Antibody Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 118. Aves Labs Anti-Vimentin Antibody Product
Table 119. Aves Labs Recent Developments/Updates
Table 120. Raybiotech Company Information
Table 121. Raybiotech Description and Business Overview
Table 122. Raybiotech Anti-Vimentin Antibody Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 123. Raybiotech Anti-Vimentin Antibody Product
Table 124. Raybiotech Recent Developments/Updates
Table 125. Biolegend Company Information
Table 126. Biolegend Description and Business Overview
Table 127. Biolegend Anti-Vimentin Antibody Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 128. Biolegend Anti-Vimentin Antibody Product
Table 129. Biolegend Recent Developments/Updates
Table 130. Roche Diagnostics Company Information
Table 131. Roche Diagnostics Description and Business Overview
Table 132. Roche Diagnostics Anti-Vimentin Antibody Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 133. Roche Diagnostics Anti-Vimentin Antibody Product
Table 134. Roche Diagnostics Recent Developments/Updates
Table 135. Rockland Immunochemicals Company Information
Table 136. Rockland Immunochemicals Description and Business Overview
Table 137. Rockland Immunochemicals Anti-Vimentin Antibody Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 138. Rockland Immunochemicals Anti-Vimentin Antibody Product
Table 139. Rockland Immunochemicals Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Anti-Vimentin Antibody Distributors List
Table 143. Anti-Vimentin Antibody Customers List
Table 144. Anti-Vimentin Antibody Market Trends
Table 145. Anti-Vimentin Antibody Market Drivers
Table 146. Anti-Vimentin Antibody Market Challenges
Table 147. Anti-Vimentin Antibody Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Anti-Vimentin Antibody
Figure 2. Global Anti-Vimentin Antibody Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Anti-Vimentin Antibody Market Share by Type: 2025 & 2032
Figure 4. Monoclonal Anti-Vimentin Antibody Product Picture
Figure 5. Polyclonal Anti-Vimentin Antibody Product Picture
Figure 6. Global Anti-Vimentin Antibody Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Anti-Vimentin Antibody Market Share by Application: 2025 & 2032
Figure 8. Immunocytochemistry
Figure 9. Flow Cytometry
Figure 10. Immunochemistry
Figure 11. Western Blot
Figure 12. Others
Figure 13. Global Anti-Vimentin Antibody Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Anti-Vimentin Antibody Market Size (US$ Million), 2021–2032
Figure 15. Global Anti-Vimentin Antibody Sales (kg), 2021–2032
Figure 16. Global Anti-Vimentin Antibody Average Price (US$/kg), 2021–2032
Figure 17. Anti-Vimentin Antibody Report Years Considered
Figure 18. Anti-Vimentin Antibody Sales Share by Manufacturers in 2025
Figure 19. Global Anti-Vimentin Antibody Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Anti-Vimentin Antibody Players: Market Share by Revenue in Anti-Vimentin Antibody in 2025
Figure 21. Anti-Vimentin Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Anti-Vimentin Antibody Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Anti-Vimentin Antibody Sales Market Share by Country (2021–2032)
Figure 24. North America Anti-Vimentin Antibody Revenue Market Share by Country (2021–2032)
Figure 25. United States Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Anti-Vimentin Antibody Sales Market Share by Country (2021–2032)
Figure 28. Europe Anti-Vimentin Antibody Revenue Market Share by Country (2021–2032)
Figure 29. Germany Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Anti-Vimentin Antibody Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Anti-Vimentin Antibody Revenue Market Share by Region (2021–2032)
Figure 36. China Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Anti-Vimentin Antibody Sales Market Share by Country (2021–2032)
Figure 44. Latin America Anti-Vimentin Antibody Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Anti-Vimentin Antibody Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Anti-Vimentin Antibody Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Anti-Vimentin Antibody by Type (2021–2032)
Figure 55. Global Revenue Market Share of Anti-Vimentin Antibody by Type (2021–2032)
Figure 56. Global Anti-Vimentin Antibody Price (US$/kg) by Type (2021–2032)
Figure 57. Global Sales Market Share of Anti-Vimentin Antibody by Application (2021–2032)
Figure 58. Global Revenue Market Share of Anti-Vimentin Antibody by Application (2021–2032)
Figure 59. Global Anti-Vimentin Antibody Price (US$/kg) by Application (2021–2032)
Figure 60. Anti-Vimentin Antibody Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Natural Cocoa Extracts Market Research Report 2026
May 01, 26
Global Semiconductor Switched Mode Power Supply Market Research Report 2026
May 01, 26
Global Silicone Coated Spandrel Glass Market Research Report 2026
May 01, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232